Skip to main content
Erschienen in: Medical Microbiology and Immunology 1/2011

01.02.2011 | Review

Hidden hazards of HCV transmission

verfasst von: Robério Amorim de Almeida Pondé

Erschienen in: Medical Microbiology and Immunology | Ausgabe 1/2011

Einloggen, um Zugang zu erhalten

Abstract

Hepatitis C virus infection is a global health problem that has important epidemiological and clinical consequences. It has been well established that exposure to infected blood is the main risk factor for HCV transmission. However, in 20% of cases the agent transmission occurs by unknown route or in the presence of an unidentified source of infection. Understanding of the epidemiology of HCV is needed to help us define future control and preventive strategies. Herein, we discuss about diagnosis of HCV infection and hepatitis C surveillance in the context of its transmission.
Literatur
1.
Zurück zum Zitat Kao JH, Chen DS (2000) Transmission of hepatitis C virus in Asia: past and present perspectives. J Gastroenterol Hepatol 15(Suppl):E91–E96CrossRefPubMed Kao JH, Chen DS (2000) Transmission of hepatitis C virus in Asia: past and present perspectives. J Gastroenterol Hepatol 15(Suppl):E91–E96CrossRefPubMed
2.
Zurück zum Zitat Hwang SJ, Lee SD, Lu RH (2001) Hepatitis C viral genotype influences the clinical outcome of patients with acute post-transfusion hepatitis C. J Med Virol 65:505–509CrossRefPubMed Hwang SJ, Lee SD, Lu RH (2001) Hepatitis C viral genotype influences the clinical outcome of patients with acute post-transfusion hepatitis C. J Med Virol 65:505–509CrossRefPubMed
3.
Zurück zum Zitat Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265):798–801CrossRefPubMed Thomas DL, Thio CL, Martin MP, Qi Y, Ge D, O’Huigin C, Kidd J, Kidd K, Khakoo SI, Alexander G, Goedert JJ, Kirk GD, Donfield SM, Rosen HR, Tobler LH, Busch MP, McHutchison JG, Goldstein DB, Carrington M (2009) Genetic variation in IL28B and spontaneous clearance of hepatitis C virus. Nature 461(7265):798–801CrossRefPubMed
4.
Zurück zum Zitat Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM (2007) Studying Hepatitis C virus: making the best of a bad virus. J Virol 81(17):8853–8867CrossRefPubMed Tellinghuisen TL, Evans MJ, von Hahn T, You S, Rice CM (2007) Studying Hepatitis C virus: making the best of a bad virus. J Virol 81(17):8853–8867CrossRefPubMed
5.
Zurück zum Zitat Alter M (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44:6–9CrossRef Alter M (2006) Epidemiology of viral hepatitis and HIV co-infection. J Hepatol 44:6–9CrossRef
6.
Zurück zum Zitat Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616CrossRefPubMed Prati D (2006) Transmission of hepatitis C virus by blood transfusions and other medical procedures: a global review. J Hepatol 45:607–616CrossRefPubMed
7.
Zurück zum Zitat Schreiber G, Busch M, Kleinman S, Korelitz J (1996) The risk of transfusion-transmitted viral infections. N Eng J Med 26(334):1687–1690 Schreiber G, Busch M, Kleinman S, Korelitz J (1996) The risk of transfusion-transmitted viral infections. N Eng J Med 26(334):1687–1690
8.
Zurück zum Zitat Roy KM, Goldberg D, Taylor A, Mills P (2003) Investigation the source of hepatitis C virus infection among individuals whose route of infection is undefined: a study of ten cases. Scan J Infect Dis 35:326–328CrossRef Roy KM, Goldberg D, Taylor A, Mills P (2003) Investigation the source of hepatitis C virus infection among individuals whose route of infection is undefined: a study of ten cases. Scan J Infect Dis 35:326–328CrossRef
9.
Zurück zum Zitat Blackard JT, Shata MT, Shire NJ, Sherman KE (2008) Acute hepatitis C virus infection: a chronic problem. Hepatology 47(1):321–331CrossRefPubMed Blackard JT, Shata MT, Shire NJ, Sherman KE (2008) Acute hepatitis C virus infection: a chronic problem. Hepatology 47(1):321–331CrossRefPubMed
10.
Zurück zum Zitat Giachetti C, Linnen J, Kolk D, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick M, Mimms L, McDonough S (2002) Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 7(40):2408–2419CrossRef Giachetti C, Linnen J, Kolk D, Dockter J, Gillotte-Taylor K, Park M, Ho-Sing-Loy M, McCormick M, Mimms L, McDonough S (2002) Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol 7(40):2408–2419CrossRef
11.
Zurück zum Zitat Kolk D, Dockter J, Linnen J, Ho-Sing-Loy M, Gillotte-Taylor K, McDonough S, Mimms L, Giachetti C (2002) Significant closure of the Human Immunodeficiency Virus Type 1 and Hepatitis C Virus preseroconversion detection windows with a transcription-mediated-amplification driven assay. J Clin Microbiol 5(40):1761–1766CrossRef Kolk D, Dockter J, Linnen J, Ho-Sing-Loy M, Gillotte-Taylor K, McDonough S, Mimms L, Giachetti C (2002) Significant closure of the Human Immunodeficiency Virus Type 1 and Hepatitis C Virus preseroconversion detection windows with a transcription-mediated-amplification driven assay. J Clin Microbiol 5(40):1761–1766CrossRef
12.
Zurück zum Zitat Idrees M, Riazuddin S (2008) Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Inf Dis 8:69CrossRef Idrees M, Riazuddin S (2008) Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission. BMC Inf Dis 8:69CrossRef
13.
Zurück zum Zitat Rè V, Gallego S, Farías A, Barbás G, Kremer L, Díaz M, Contigiani M (2008) Hepatitis C and HIV coinfection in central region of Argentina: prevalence, genotype characterization and risk factors. Enferm Infecc Microbiol Clin 26(7):423–425CrossRefPubMed Rè V, Gallego S, Farías A, Barbás G, Kremer L, Díaz M, Contigiani M (2008) Hepatitis C and HIV coinfection in central region of Argentina: prevalence, genotype characterization and risk factors. Enferm Infecc Microbiol Clin 26(7):423–425CrossRefPubMed
14.
Zurück zum Zitat Abou-Setta AM (2004) Transmission risk of hepatitis C virus via semen during assisted reproduction: how reals is it? Hum Reprod 12(19):2711–2717CrossRef Abou-Setta AM (2004) Transmission risk of hepatitis C virus via semen during assisted reproduction: how reals is it? Hum Reprod 12(19):2711–2717CrossRef
15.
Zurück zum Zitat Thompson S, Boughton C, Dore G (2003) Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified? Aust N Z J Public Health 27(6):602–607CrossRefPubMed Thompson S, Boughton C, Dore G (2003) Blood-borne viruses and their survival in the environment: is public concern about community needlestick exposures justified? Aust N Z J Public Health 27(6):602–607CrossRefPubMed
16.
Zurück zum Zitat Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, Prins M (2009) Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 23(12):F1–F7CrossRefPubMed Urbanus AT, van de Laar TJ, Stolte IG, Schinkel J, Heijman T, Coutinho RA, Prins M (2009) Hepatitis C virus infections among HIV-infected men who have sex with men: an expanding epidemic. AIDS 23(12):F1–F7CrossRefPubMed
17.
Zurück zum Zitat Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, Fischer M, Johnson AM, Dusheiko GM (2007) Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21(8):983–991CrossRefPubMed Danta M, Brown D, Bhagani S, Pybus OG, Sabin CA, Nelson M, Fischer M, Johnson AM, Dusheiko GM (2007) Recent epidemic of acute hepatitis C virus in HIV-positive men who have sex with men linked to high-risk sexual behaviours. AIDS 21(8):983–991CrossRefPubMed
18.
Zurück zum Zitat van de Laar TJ, van der Laar Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, van der Meer JT, de Vries HJ, Mulder JW, van Agtmael M, Jurriaans S, Wolthers KC, Coutinho RA (2007) Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 196(2):230–238CrossRefPubMed van de Laar TJ, van der Laar Bij AK, Prins M, Bruisten SM, Brinkman K, Ruys TA, van der Meer JT, de Vries HJ, Mulder JW, van Agtmael M, Jurriaans S, Wolthers KC, Coutinho RA (2007) Increase in HCV incidence among men who have sex with men in Amsterdam most likely caused by sexual transmission. J Infect Dis 196(2):230–238CrossRefPubMed
19.
Zurück zum Zitat Indolfi G, Rest M (2009) Perinatal transmission of hepatitis C virus infection. J Med Virol 81(5):836–843CrossRefPubMed Indolfi G, Rest M (2009) Perinatal transmission of hepatitis C virus infection. J Med Virol 81(5):836–843CrossRefPubMed
20.
Zurück zum Zitat Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H (2003) Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 187(3):345–351CrossRefPubMed Steininger C, Kundi M, Jatzko G, Kiss H, Lischka A, Holzmann H (2003) Increased risk of mother-to-infant transmission of hepatitis C virus by intrapartum infantile exposure to maternal blood. J Infect Dis 187(3):345–351CrossRefPubMed
21.
Zurück zum Zitat Mok J, Pembrey L, Tovo P-A, Newell M-L (2004) When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal 90:156–160CrossRef Mok J, Pembrey L, Tovo P-A, Newell M-L (2004) When does mother to child transmission of hepatitis C virus occur? Arch Dis Child Fetal Neonatal 90:156–160CrossRef
22.
Zurück zum Zitat Kumar RM, Shahul S (1998) Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 29(2):191–197CrossRefPubMed Kumar RM, Shahul S (1998) Role of breast-feeding in transmission of hepatitis C virus to infants of HCV-infected mothers. J Hepatol 29(2):191–197CrossRefPubMed
23.
Zurück zum Zitat Otedo AE, McLigeyo SO, Okoth FA, Kayima JK (2003) Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J 93(5):380–384PubMed Otedo AE, McLigeyo SO, Okoth FA, Kayima JK (2003) Seroprevalence of hepatitis B and C in maintenance dialysis in a public hospital in a developing country. S Afr Med J 93(5):380–384PubMed
24.
Zurück zum Zitat Sakai N, Tatsuta M, Iishi H, Yano H, Osaka S, Aoki A (2001) Effectiveness of manual cleaning and disinfection of gastroendoscopes with 3% glutaraldehyde for decreasing the risk of transmission of Hepatitis C virus. Am J Gastroenterol 96(6):1803–1806CrossRefPubMed Sakai N, Tatsuta M, Iishi H, Yano H, Osaka S, Aoki A (2001) Effectiveness of manual cleaning and disinfection of gastroendoscopes with 3% glutaraldehyde for decreasing the risk of transmission of Hepatitis C virus. Am J Gastroenterol 96(6):1803–1806CrossRefPubMed
25.
Zurück zum Zitat Center for Disease Control and Prevention (CDC) (2008) Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic—Nevada. MMWR 57(19):513–517 Center for Disease Control and Prevention (CDC) (2008) Acute hepatitis C virus infections attributed to unsafe injection practices at an endoscopy clinic—Nevada. MMWR 57(19):513–517
26.
Zurück zum Zitat Pekova L, Teocharov P, Sakarev A (2007) Clinical course and outcome of a nosocomial outbreak of hepatitis C in a urology ward. J Hosp Inf 67:86–91CrossRef Pekova L, Teocharov P, Sakarev A (2007) Clinical course and outcome of a nosocomial outbreak of hepatitis C in a urology ward. J Hosp Inf 67:86–91CrossRef
27.
Zurück zum Zitat Lédinghen V, Trimoulet P, Cazajous G, Bernard P-H, Schrive M-H, Foucher J, Faure M, Castéra L, Vergniol J, Amouretti M, Fleury H, Couzigou P (2003) Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins. J Med Virol 76:279–284CrossRef Lédinghen V, Trimoulet P, Cazajous G, Bernard P-H, Schrive M-H, Foucher J, Faure M, Castéra L, Vergniol J, Amouretti M, Fleury H, Couzigou P (2003) Epidemiological and phylogenetic evidence for patient-to-patient hepatitis C virus transmission during sclerotherapy of varicose veins. J Med Virol 76:279–284CrossRef
28.
Zurück zum Zitat Froio N, Nicastri E, Comandini U, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N (2003) Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 42(3):546–550CrossRefPubMed Froio N, Nicastri E, Comandini U, Cherubini C, Felicioni R, Solmone M, Di Giulio S, Petrosillo N (2003) Contamination by hepatitis B and C viruses in the dialysis setting. Am J Kidney Dis 42(3):546–550CrossRefPubMed
29.
Zurück zum Zitat Monsalve-Castillo F, Gomez-Gamboa L (2004) Hepatitis C virus. Iatrogenic and nosocomial transmition? Invest Clin 45(3):193–195PubMed Monsalve-Castillo F, Gomez-Gamboa L (2004) Hepatitis C virus. Iatrogenic and nosocomial transmition? Invest Clin 45(3):193–195PubMed
30.
Zurück zum Zitat Forns X, Martinèz-Bauer E, Feliu A, García-Retortillo M, Martin M, Gay E, Nevasa M, Sanchez-Tapias J, Bruguera M, Rodes J (2005) Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 41(1):115–122CrossRefPubMed Forns X, Martinèz-Bauer E, Feliu A, García-Retortillo M, Martin M, Gay E, Nevasa M, Sanchez-Tapias J, Bruguera M, Rodes J (2005) Nosocomial transmission of HCV in the liver unit of a tertiary care center. Hepatology 41(1):115–122CrossRefPubMed
31.
Zurück zum Zitat Beltrami EM, Williams IT, Shapiro CN, Chamberland ME (2000) Risk and management of blood-borne infection in health care workers. Clin Microbiol Rev 13(3):385–407CrossRefPubMed Beltrami EM, Williams IT, Shapiro CN, Chamberland ME (2000) Risk and management of blood-borne infection in health care workers. Clin Microbiol Rev 13(3):385–407CrossRefPubMed
32.
Zurück zum Zitat Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, Thomas T, Deuffic-Burban S, Prevot MH, Domart M, Tarantola A, Abiteboul D, Deny P, Pol S, Desenclos JC, Puro V, Bouvet E (2005) Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: European case-control study. Clin Infect Dis 41(1):1423–1430CrossRefPubMed Yazdanpanah Y, De Carli G, Migueres B, Lot F, Campins M, Colombo C, Thomas T, Deuffic-Burban S, Prevot MH, Domart M, Tarantola A, Abiteboul D, Deny P, Pol S, Desenclos JC, Puro V, Bouvet E (2005) Risk factors for hepatitis C virus transmission to health care workers after occupational exposure: European case-control study. Clin Infect Dis 41(1):1423–1430CrossRefPubMed
33.
Zurück zum Zitat Raggam RB, Rossmann AM, Salzer HJ, Stauber RE, Kessler HH (2009) Health care worker-to-patient transmission of hepatitis C virus in the health care setting: many questions and few answers. J Clin Virol 45(4):272–275CrossRefPubMed Raggam RB, Rossmann AM, Salzer HJ, Stauber RE, Kessler HH (2009) Health care worker-to-patient transmission of hepatitis C virus in the health care setting: many questions and few answers. J Clin Virol 45(4):272–275CrossRefPubMed
34.
Zurück zum Zitat Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott E, Shaw-Stiffel T, Weston S, Theide H, Wald A, Rosen H (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Inf Dis 196:1474–1482CrossRef Wang CC, Krantz E, Klarquist J, Krows M, McBride L, Scott E, Shaw-Stiffel T, Weston S, Theide H, Wald A, Rosen H (2007) Acute hepatitis C in a contemporary US cohort: modes of acquisition and factors influencing viral clearance. J Inf Dis 196:1474–1482CrossRef
35.
Zurück zum Zitat Murphy E, Bryzman S, Glynn S, Ameti D, Thomson R, Willian A, Nass C, Ownby H, Screiber G, Kong F, Neal F, Nemo G (2000) Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 31(3):756–762CrossRefPubMed Murphy E, Bryzman S, Glynn S, Ameti D, Thomson R, Willian A, Nass C, Ownby H, Screiber G, Kong F, Neal F, Nemo G (2000) Risk factors for hepatitis C virus infection in United States blood donors. Hepatology 31(3):756–762CrossRefPubMed
36.
Zurück zum Zitat Raguin G, Rosenthal E, Cacoub P, Veyssier P, Piette JC, Micoud M (1998) Hepatitis C in France: a national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases). Eur J Epidemiol 14(1):545–548CrossRefPubMed Raguin G, Rosenthal E, Cacoub P, Veyssier P, Piette JC, Micoud M (1998) Hepatitis C in France: a national survey in the Departments of Internal Medicine and Infectious Diseases. The GERMIVIC (Joint Study Group on Hepatitis C Virus of the French National Society of Internal Medicine and the French Society of Infectious Diseases). Eur J Epidemiol 14(1):545–548CrossRefPubMed
37.
Zurück zum Zitat Ferrero MC, Dios PD, Scully C (2005) Transmission of hepatitis C virus by saliva? Oral Dis 11:230–235CrossRef Ferrero MC, Dios PD, Scully C (2005) Transmission of hepatitis C virus by saliva? Oral Dis 11:230–235CrossRef
38.
Zurück zum Zitat Macías J, Palacios R, Claro E, Vargas J, Vergara S, Mira J, Merchante N, Corzo J, Pineda J (2008) High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Inter 28(6):781–786CrossRef Macías J, Palacios R, Claro E, Vargas J, Vergara S, Mira J, Merchante N, Corzo J, Pineda J (2008) High prevalence of hepatitis C virus infection among noninjecting drug users: association with sharing the inhalation implements of crack. Liver Inter 28(6):781–786CrossRef
39.
Zurück zum Zitat van den Berg C, van de Laar T, Kok A, Zuure F, Coutinho R, Prins M (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577CrossRefPubMed van den Berg C, van de Laar T, Kok A, Zuure F, Coutinho R, Prins M (2009) Never injected, but hepatitis C virus-infected: a study among self-declared never-injecting drug users from the Amsterdam Cohort Studies. J Viral Hepat 16:568–577CrossRefPubMed
40.
Zurück zum Zitat Coppola N, Pisapia R, Marrocco C, Martini S, Vatiero LM, Messina V, Tonziello G, Sagnelli C, Filippini P, Piccinino F, Sagnelli E (2007) Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol 40(2):110–115CrossRefPubMed Coppola N, Pisapia R, Marrocco C, Martini S, Vatiero LM, Messina V, Tonziello G, Sagnelli C, Filippini P, Piccinino F, Sagnelli E (2007) Anti-HCV IgG avidity index in acute hepatitis C. J Clin Virol 40(2):110–115CrossRefPubMed
41.
Zurück zum Zitat Sagnelli E, Coppola N, Marrocco C, Coviello G, Battaglia M, Messina V, Rossi G, Sagnelli C, Scolastico C, Filippini P (2005) Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol 42(5):646–651CrossRefPubMed Sagnelli E, Coppola N, Marrocco C, Coviello G, Battaglia M, Messina V, Rossi G, Sagnelli C, Scolastico C, Filippini P (2005) Diagnosis of hepatitis C virus related acute hepatitis by serial determination of IgM anti-HCV titres. J Hepatol 42(5):646–651CrossRefPubMed
42.
Zurück zum Zitat Irving W, Salmon D, Boucher C, Hoepelman I (2008) Acute hepatitis C virus infection. EuroSurveill 13(21):1–4 (pii: 18879) Irving W, Salmon D, Boucher C, Hoepelman I (2008) Acute hepatitis C virus infection. EuroSurveill 13(21):1–4 (pii: 18879)
43.
Zurück zum Zitat Wasley A, Grytdal S, Gallagher K, Centres for Disease Control, Prevention (CDC) (2008) Surveillance for acute viral hepatitis—United States. MMWR Surveill Summ 57(2):1–24PubMed Wasley A, Grytdal S, Gallagher K, Centres for Disease Control, Prevention (CDC) (2008) Surveillance for acute viral hepatitis—United States. MMWR Surveill Summ 57(2):1–24PubMed
44.
Zurück zum Zitat Vento S, Cainelli F, Longhi M (2002) Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol 3(6):333–340CrossRefPubMed Vento S, Cainelli F, Longhi M (2002) Reactivation of replication of hepatitis B and C viruses after immunosuppressive therapy: an unresolved issue. Lancet Oncol 3(6):333–340CrossRefPubMed
45.
Zurück zum Zitat Ennishi D, Yokoyama M, Terui Y, Takeuchi K, Ikeda K, Tanimoto M, Hatake K (2008) Does rituximab really induce hepatitis C virus reactivation? J Clin Oncol 26(28):4695–4696CrossRefPubMed Ennishi D, Yokoyama M, Terui Y, Takeuchi K, Ikeda K, Tanimoto M, Hatake K (2008) Does rituximab really induce hepatitis C virus reactivation? J Clin Oncol 26(28):4695–4696CrossRefPubMed
46.
Zurück zum Zitat Cardell K, Widell A, Frydén A, Akerling B, Mansson A, Franzén S, Lymer U, Isaksson B (2008) Nosocomial hepatitis C in thoracic surgery unit; retrospective findings generating a prospective study. J Hosp Infect 68:322–328PubMed Cardell K, Widell A, Frydén A, Akerling B, Mansson A, Franzén S, Lymer U, Isaksson B (2008) Nosocomial hepatitis C in thoracic surgery unit; retrospective findings generating a prospective study. J Hosp Infect 68:322–328PubMed
47.
Zurück zum Zitat Molmenti E, Klintmalm G (2000) Hepatitis C recurrence after liver transplantation. Liver Transpl 6(4):413–414CrossRefPubMed Molmenti E, Klintmalm G (2000) Hepatitis C recurrence after liver transplantation. Liver Transpl 6(4):413–414CrossRefPubMed
48.
Zurück zum Zitat Melon S, Galarraga M, Villar M, Laures A, Boga J, de Oña M, Gomez E (2005) Hepatitis C vírus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transpl Proc 37(5):2083–2085CrossRef Melon S, Galarraga M, Villar M, Laures A, Boga J, de Oña M, Gomez E (2005) Hepatitis C vírus reactivation in anti-hepatitic C virus-positive renal transplant recipients. Transpl Proc 37(5):2083–2085CrossRef
49.
Zurück zum Zitat Chen J, Chung J, Kao J, Chen D (2001) Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 16(6):705–708CrossRefPubMed Chen J, Chung J, Kao J, Chen D (2001) Post-partum acute exacerbation of chronic hepatitis in a hepatitis C-carrier mother. J Gastroenterol Hepatol 16(6):705–708CrossRefPubMed
50.
Zurück zum Zitat Humar A, Washburn K, Freeman R, Paya C, Mouas H, Alecock E, Razonable R (2007) An assessment of interactions between hepatitis C virus and Herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl 13:1422–1427CrossRefPubMed Humar A, Washburn K, Freeman R, Paya C, Mouas H, Alecock E, Razonable R (2007) An assessment of interactions between hepatitis C virus and Herpesvirus reactivation in liver transplant recipients using molecular surveillance. Liver Transpl 13:1422–1427CrossRefPubMed
Metadaten
Titel
Hidden hazards of HCV transmission
verfasst von
Robério Amorim de Almeida Pondé
Publikationsdatum
01.02.2011
Verlag
Springer-Verlag
Erschienen in
Medical Microbiology and Immunology / Ausgabe 1/2011
Print ISSN: 0300-8584
Elektronische ISSN: 1432-1831
DOI
https://doi.org/10.1007/s00430-010-0159-9

Weitere Artikel der Ausgabe 1/2011

Medical Microbiology and Immunology 1/2011 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.